B-lines Lung Ultrasound Guided ED Management of Acute Heart Failure (BLUSHED-AHF)
B-lines Lung Ultrasound Guided ED Management of Acute Heart Failure (BLUSHED-AHF)
批准号:
9299462
负责人:
Peter S Pang
金额:
$40.02万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-04-17 至 2019-02-28
关键词:
Accident and Emergency departmentAcuteAlgorithmsAmericanBlood PressureBreathingCaringChronicCongestiveDiagnosisDiureticsEffectivenessEmergency Department PhysicianEmergency Department patientEnrollmentEnvironmental air flowExtravascular Lung WaterFailureFutureGoalsGuidelinesHeart failureHematocrit procedureHemoglobinHeterogeneityHospitalizationHospitalsHourIntravenousLearningLegLungMeasurementMeasuresMedication ManagementMorbidity - disease rateNitratesOutcomePatient CarePatientsPharmaceutical PreparationsPilot ProjectsPrognostic MarkerProtocols documentationRandomizedRecording of previous eventsRecruitment ActivityReproducibilityResearch DesignResidual stateResolutionSafetySiteSwellingTechniquesTestingTimeTreatment FailureUltrasonographyVariantWaterWeight Gainbasediagnostic accuracyevidence baseimprovedimproved outcomemortalitynovel strategiesnovel therapeuticspatient populationpilot trialtargeted treatmenttreatment as usual
中文摘要
标题:急性心力衰竭(BLUSHED-AHF)的B线肺部超声引导艾德管理
摘要
近80%的急性心力衰竭(AHF)患者入院时在急诊室接受初步治疗
部门(艾德)。一旦入院,在出院后30天内,27%的患者再次住院或死亡。
尝试用新的疗法来改善结果都失败了。现有AHF治疗的证据
差:目前没有已知的AHF治疗可以改善结局。艾德治疗在很大程度上是相同的
40年前的今天。充血,如呼吸困难,体重增加和腿部肿胀,是主要的
患者因AHF而住院的原因。治疗充血是AHF的基石
管理然而,一半的AHF患者离开医院时没有充分缓解充血。我们提出了一种新
艾德环境中积极缓解患者充血的方法:肺部超声引导、方案驱动、AHF
管理LUS B线是血管外肺水(EVLW)的量度。在AHF的设置中,LUS是
一种衡量拥挤程度的方法。这种简单易学的技术具有出色的可靠性和再现性。我们
假设护理策略将优于常规护理。目前,常规护理主要是
经验主义本研究将为艾德急性心力衰竭的治疗提供更多的证据。这项试点研究,如果
成功,将导致一项结果试验,检查艾德AHF护理策略是否增加生存天数
和医院外的病人。
英文摘要
Title: B-lines Lung Ultrasound Guided ED Management of Acute Heart Failure (BLUSHED-AHF)
ABSTRACT
Nearly 80% of acute heart failure (AHF) patients admitted to the hospital are initially treated in the emergency
department (ED). Once admitted, within 30 days post-discharge, 27% of patients are re-hospitalized or die.
Attempts to improve outcomes with novel therapies have all failed. The evidence for existing AHF therapies
are poor: No currently used AHF treatment is known to improve outcomes. ED treatment is largely the same
today as 40 years ago. Congestion, such as difficulty breathing, weight gain, and leg swelling, is the primary
reason why patients present to the hospital for AHF. Treating congestion is the cornerstone of AHF
management. Yet half of all AHF patients leave the hospital inadequately decongested. We propose a novel
approach to aggressively decongest patients in the ED setting: lung ultrasound guided, protocol driven, AHF
management. LUS B-lines are a measure of extra-vascular lung water (EVLW). In the setting of AHF, LUS are
a measure of congestion. This simple, easily learned technique has excellent reliability and reproducibility. We
hypothesize that a strategy-of-care will outperform usual care. At the present time, usual care is largely
empirical. This study will improve the evidence base for ED AHF management. This proposed pilot study, if
successful, will lead to an outcome trial examining whether an ED AHF strategy-of-care increases days alive
and out of the hospital for patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Using Short Stay Units (SSU) Instead of Routine Admission to Improve Patient Centered Health Outcomes for Acute Heart Failure (AHF) Patients.
-
批准号:9366626
-
项目类别:
-
资助金额:$39.99万
-
财政年份:2017
-
负责人:Peter S Pang
-
依托单位:
B-lines Lung Ultrasound Guided ED Management of Acute Heart Failure (BLUSHED-AHF)
-
批准号:9473074
-
项目类别:
-
资助金额:$35.83万
-
财政年份:2017
-
负责人:Peter S Pang
-
依托单位:
海外基金